Micro-Tech's H1 Revenue Up 10.39%, Net Profit Down 16.5%
Micro-Tech Medical reported H1 2026 revenue of RMB 1.728 billion, up 10.39% year-on-year, while net profit attributable to shareholders fell 16.5% to RMB 303 million. The company proposed a cash dividend of RMB 5.0 per 10 shares (tax inclusive). A RMB 83 million exchange loss from RMB appreciation weighed on first-half earnings.
Micro-Tech Medical disclosed its interim report on August 26, showing revenue of RMB 1.728 billion for the first half of 2026, a year-on-year increase of 10.39%. Net profit attributable to shareholders of the listed company stood at RMB 303 million, down 16.5% from a year earlier. Basic earnings per share were RMB 1.63. The company proposed a cash dividend of RMB 5.0 per 10 shares (tax inclusive).
During the reporting period, the company's exposure to foreign-currency funds and monetary assets remained high. Affected by the appreciation of the RMB, the conversion of foreign-currency asset exposure generated an exchange loss of RMB 83 million, which had a short-term negative impact on first-half profit.